Found 9 matching trials
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
PHASE2Our main objective is to evaluate the effect of Ocoxin-Viusid on the qualit...
Location
National Institute of Oncology and Radiobiology (INOR)
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.
PHASE2Oral mucositis is one of the most spread side effects of anticancer therapy...
Location
Medical Scientific centre of professor Shumsky
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
NAExploratory study to evaluate the effect and safety of the use of Ocoxin® o...
Location
Hospital Escuela, Tegucigalpa (Honduras)
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
PHASE2Our hypothesis is: the nutritional supplement Ocoxin-viusid improves the qu...
Location
National Institute of Oncology and Radiobiology (INOR)
Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study
NAERAS (Enhanced Recovery After Surgery) protocols are step-by-step care plan...
Location
General Hospital of Papageorgiou
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
PHASE2The research product, registered as a nutritional supplement (Ocoxin®, oral...
Location
National Institute of Oncology and Radiobiology (INOR)
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
PHASE2The investigators hypothesized that with the administration of the nutritio...
Location
"Hermanos Ameijeiras" Surgical Clinical Hospital
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
PHASE2Phase II clinical trial, monocentric, not controlled, in patients with high...
Location
Our Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
Evaluation of Ocoxin®-Viusid® in Breast Cancer
PHASE2The purpose is to determine the efficacy of the nutritional supplement Ocox...
Location
National Institute of Oncology and Radiobiology (INOR)